Researchers at Michigan University have discovered the first of its kind non-invasive, non-ionizing, and non-thermal ablation ...
Pulse Biosciences (Nasdaq:PLSE) today announced clinical study results from a first-in-human study of its nPulse system.
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the ...
Cardiovascular disease (CVD) is the leading cause of death in Europe. For decades, public health strategies have focused on ...
Healthcare Trend Analysis Reveals Shift Toward Non-Invasive Pre-Surgical Evaluation as Multi-Modal Compression Technology Addresses Growing Patient Demand for Evidence-Based Alternatives ...
RetinalGenix Technologies Inc.[OTCQB: RTGN] ('RetinalGenix” or the 'Company”), a company developing ultra-high-resolution ...
Medcare Hospital Al Safa introduces new AI diagnostic technologies to detect & predict onset of cardio related diseases ...
Dr. Rothstein brings more than four decades of clinical, academic, and leadership experience in emergency medicine, mental ...
The final milestone in the current roadmap is D19, projected for 2028. This device will incorporate three additional blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback